Correction and maintenance study of subcutaneous injections of R744 to predialysis patients (phase III, comparative study in comparison with epoetin beta)
Phase of Trial: Phase III
Latest Information Update: 27 May 2016
At a glance
- Drugs Epoetin beta; Methoxy polyethylene glycol-epoetin beta
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 06 Jan 2009 Status changed from active, no longer recruiting to completed.
- 09 Jun 2008 The expected completion date for this trial is now 1 Jan 2008 as reported by ClinicalTrials.gov.
- 29 Jan 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov